1,066 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

Acorda Competitors or Alternatives

Acorda's top competitors include Alexza, Pulmatrix and Vectura.

Unlock 24 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Acorda's company profile

Ron Cohen

President & CEO

87/100
102
$182.3M
$115.7M
  • $182.3M
    $115.7M
  • 102
    $182.3M
  • $115.7M
  • 87/100
  • 102
  • $182.3M
  • $115.7M
View ProfileView
1
Acorda's Competitor - Alexza logo

Tatjana Naranda

President

72/100
25 - 100
$222.9M
$5M - 25M
  • $222.9M
    $5M - 25M
  • 25 - 100
    $222.9M
  • $5M - 25M
  • 72/100
  • 25 - 100
  • $222.9M
  • $5M - 25M
View ProfileView
2
Acorda's Competitor - Pulmatrix logo

Ted Raad

CEO

92/100
20
$155.7M
$7.8M
  • $155.7M
    $7.8M
  • 20
    $155.7M
  • $7.8M
  • 92/100
  • 20
  • $155.7M
  • $7.8M
View ProfileView
3
Acorda's Competitor - Vectura logo

Will Downie

CEO

90/100
500 - 1,000
- -
$100M - 500M
  • - -
    $100M - 500M
  • 500 - 1,000
    - -
  • $100M - 500M
  • 90/100
  • 500 - 1,000
  • - -
  • $100M - 500M
View ProfileView
4
Acorda's Competitor - InVivo logo

Richard Toselli

President & CEO

82/100
1 - 25
$50.8M
$500M - 1B
  • $50.8M
    $500M - 1B
  • 1 - 25
    $50.8M
  • $500M - 1B
  • 82/100
  • 1 - 25
  • $50.8M
  • $500M - 1B
View ProfileView
5
Acorda's Competitor - Merck logo

Robert M. Davis

Chairman & CEO

78/100
69,000
$8B
$64.2B
  • $8B
    $64.2B
  • 69,000
    $8B
  • $64.2B
  • 78/100
  • 69,000
  • $8B
  • $64.2B
View ProfileView
Acorda's top 27 competitors are Alexza, Pulmatrix, Vectura, MannKind, InVivo, Merck, Pfizer, Advanced Cancer Therapeutics, LLC, Cynapsus, Novartis, Pure, GSK, Impel Pharma, AbbVie, Gilead, Sanofi, Genentech, Abbott, Cipla, Bayer , Biogen, Minerva Neurosciences, Neuroderm, Oncodrone, NeuroNascent, Voyager and TEVA. Together they have raised over 42.5B between their estimated 764.1K employees. Acorda has 102 employees and is ranked 18th among it's top 10 competitors. The top 10 competitors average 29,392.

Acorda VS Alexza

Alexza is one of Acorda's top rivals. Alexza is a Private company that was founded in 2000 in Mountain View, California. Like Acorda, Alexza also works within the Pharmaceuticals & Biotechnology industry. Compared to Acorda, Alexza has 22 fewer employees.

Acorda VS Vectura

Vectura is one of Acorda's top competitors. Vectura was founded in 1997, and its headquarters is in Chippenham, England. Like Acorda, Vectura also competes in the Pharmaceuticals & Biotechnology space. Vectura has 408 more employees than Acorda.

Looking for similar companies to Acorda?

Similar Companies

Companies in Ardsley with employees in 100-250 range

See 13 companies 
Biotechnology companies with revenue in $100-500M range

See 234 companies 
Biotechnology companies in New York

See 660 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100-500M range

See 566 companies 
Biotechnology companies in New York Metropolitan Area

See 859 companies 
Biotechnology companies with employees in 100-250 range

See 1,100 companies 
Pharmaceuticals & Biotechnology companies in New York

See 1,119 companies 
Companies in New York with revenue in $100-500M range

See 1,279 companies 
Companies in New York Metropolitan Area with revenue in $100-500M range

See 1,499 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Acorda and Acorda's Competitors

April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE:MRK) of a c...
April 1, 2025PMLiVE
The authorisation approximately triples the number of patients eligible to receive the therapy...
Today 10:03 AMPharmabiz
Pfizer Inc. announced that the European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, the company's bivalent ...
April 1, 2025StreetInsider
New York, New York--(Newsfile Corp. - April 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositar...
March 31, 2025Seeking Alpha
March 31, 2025PR Newswire
/PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from its TRILUMINATE Pivotal trial that show the TriClip transcatheter edge-to-ed...
March 31, 2025Pharmabiz
The US Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adu...
April 1, 2025Openpr
DelveInsight's "Thyroid Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Thyroid Cancer...
April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") MRK of a class ac...
April 1, 2025Korea Biomedical Review
Novartis has scored a win in Korea's reimbursement system, clearing its immunosuppressant Cosentyx (secukinumab) for use in children and teens with chr...

Frequently Asked Questions about Acorda

  1. Who are Acorda's top competitors?

    Acorda's top 3 competitors are Alexza, Pulmatrix, Vectura.

  2. Who is similar to Acorda?

    Alexza is the most similar to Acorda. Pulmatrix and Vectura are also similar to Acorda.

  1. Are Acorda and Alexza competitors?

    Yes, Alexza is one of Acorda’s top competitors.